O. Inoue et al., Discrepancies in apparent dopamine D2 receptor occupancy between H-3-raclopride and H-3-N-methylspiperone, J NEURAL TR, 106(11-12), 1999, pp. 1099-1104
Competitive inhibition of H-3-raclopride (RAC) and H-3-N-methylspiperone (N
MSP) binding against haloperidol, raclopride and NMSP was measured in the m
ouse striatum. H-3-RAC binding was more sensitive to competitive inhibition
by all three compounds compared with H-3-NMSP. For example, 0.3 mg/kg of h
aloperidol resulted in 95% inhibition of H-3-RAC binding, however only 60%
of inhibition of H-3-NMSP binding was found at the same dose of haloperidol
. The cross-inhibition experiments using nonradioactive RAC or NMSP as comp
etitors indicated different binding sites for H-3-RAC and H-3-NMSP in mouse
striatum. Specifically, about 40% of H-3-NMSP binding was not displaced by
treatment with a very high dose of raclopride (3 mg/kg). The time course o
f inhibition of the specific binding of H-3-RAC and H-3-NMSP were measured
following i.p. injection of 0.5 mg/kg of haloperidol. No significant differ
ences in the kinetics of haloperidol inhibition were observed between two r
adioligands.